Get started
Work

Abstract PS12-08: MORPHEUS Hormone Receptor-Positive Breast Cancer: interim analysis of a Phase Ib/II, study of fulvestrant ± atezolizumab and abemaciclib triplet treatment in patients metastatic disease

Year: 2024
Type: conference-abstract
DOI: 10.1158/1538-7445.sabcs23-ps12-08
Authors: Kyung Hae Jung, Seock-Ah Im, Denise Yardley, Sara Hurvitz, Keun Seok Lee, Amir Sonnenblick, Shlomit Shachar, Antoinette Tan, Elizabeth Comen, Einav Gal-Yam, Adam Brufsky, Hope Rugo, Jing Zhu, Kelly DuPree, Vanessa Breton, Fiona Young, Richard Schwab, Edward Cha, Melinda Telli
Institutions: Asan Medical Center, University of Ulsan, Seoul National University, Seoul National University Hospital, Sarah Cannon, Tennessee Oncology, Fred Hutch Cancer Center, National Cancer Center, Tel Aviv University, Tel Aviv Sourasky Medical Center, Levine Cancer Institute, Memorial Sloan Kettering Cancer Center, Sheba Medical Center, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Roche (United Kingdom), Stanford Medicine, Stanford University
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4396599772
Cites:
Cited by: 8
Related to: 10